New Diabetes Products 2014

  • Farxiga (dapagliflozin; AstraZeneca)

    Farxiga (dapagliflozin; AstraZeneca)

    Indication: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

  • Invokamet (canagliflozin, metformin HCl; Janssen)

    Invokamet (canagliflozin, metformin HCl; Janssen)

    Indication: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are not adequately controlled on a regimen containing metformin or canagliflozin or who are already being treated with both canagliflozin and metformin.

  • Jardiance (empagliflozin; Boehringer Ingelheim and Lilly)

    Jardiance (empagliflozin; Boehringer Ingelheim and Lilly)

    Indication: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

  • Tanzeum (albiglutide; GlaxoSmithKline)

    Tanzeum (albiglutide; GlaxoSmithKline)

    Indication: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

  • Trulicity (dulaglutide; Lilly)

    Trulicity (dulaglutide; Lilly)

    Indication: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

  • Xigduo XR (dapagliflozin, metformin HCl ext-rel; AstraZeneca)

    Xigduo XR (dapagliflozin, metformin HCl ext-rel; AstraZeneca)

    Indication: As an adjunct treatment to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both dapagliflozin and metformin is appropriate.

Next Prev